tailieunhanh - PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system and has high morbidity and mortality rates. It is essential to search new biomarkers to improve the accuracy of early HCC diagnosis. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN